To be or not to be: navigating the influence of MicroRNAs on cervical cancer cell death

被引：0

作者：

Mohammad Taghizadieh ^{[1
]}

Masoumeh Kalantari ^{[2
]}

Roksana Bakhshali ^{[3
]}

Sepehr Kobravi ^{[4
]}

Shayan Khalilollah ^{[5
]}

Hossein Bannazadeh Baghi ^{[6
]}

Mobina Bayat ^{[6
]}

Javid Sadri Nahand ^{[6
]}

Reza Akhavan-Sigari ^{[7
]}

机构：

[1] Department of Pathology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz

[2] Department of Biology, Tehran University of health Sciences, Tehran

[3] Omid Cancer Center, Ahvaz

[4] Department of Oral & Maxillofacial Surgery, Faculty of Dentistry, Tehran Medical Sciences Branch, Islamic Azad University, Tehran

[5] Department of Neurosurgery, Faculty of Medicine, Tehran Medical Sciences, Islamic Azad University, Tehran

[6] Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz

[7] Department of Neurosurgery, University Medical Center Tuebingen, Tuebingen

[8] Department of Health Care Management and Clinical Research, Collegium Humanum Warsaw Management University, Warsaw

来源：

Cancer Cell International | / 25卷 / 1期

关键词：

Apoptosis; Autophagy; Cervical cancer; Ferroptosis; MicroRNAs; Pyroptosis;

D O I：

10.1186/s12935-025-03786-y

中图分类号：

学科分类号：

摘要：

With all diagnostic and therapeutic advances, such as surgery, radiation- and chemo-therapy, cervical cancer (CC) is still ranked fourth among the most frequent cancers in women globally. New biomarkers and therapeutic targets are warranted to be discovered for the early detection, treatment, and prognosis of CC. As component of the non-coding RNA’s family, microRNAs (miRNAs) participate in several cellular functions such as cell proliferation, gene expression, many signaling cascades, apoptosis, angiogenesis, etc. MiRNAs can suppress or induce programmed cell death (PCD) pathways by altering their regulatory genes. Besides, abnormal expression of miRNAs weakens or promotes various signaling pathways associated with PCD, resulting in the development of human diseases such as CC. For that reason, understanding the effects that miRNAs exert on the various modes of tumor PCD, and evaluating the potential of miRNAs to serve as targets for induction of cell death and reappearance of chemotherapy. The current study aims to define the effect that miRNAs exert on cell apoptosis, autophagy, pyroptosis, ferroptosis, and anoikis in cervical cancer to investigate possible targets for cervical cancer therapy. Manipulating the PCD pathways by miRNAs could be considered a primary therapeutic strategy for cervical cancer. © The Author(s) 2025.

引用

共 167 条

[1] Bray F., Ferlay J., Soerjomataram I., Siegel R.L., Torre L.A., Jemal A., Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, Cancer J Clin, 68, 6, pp. 394-424, (2018)
[2] Cohen P.A., Jhingran A., Oaknin A., Denny L., Cervical cancer, Lancet, 393, pp. 169-182, (2019)
[3] Ries L., Melbert D., Krapcho M., Mariotto A., Miller B., Feuer E., Et al., National Cancer Institute
[4] Bethesda, MD: 2007, SEER Cancer Statistics Review, 1975–2004, (2007)
[5] Small W., Bacon M.A., Bajaj A., Chuang L.T., Fisher B.J., Harkenrider M.M., Et al., Cervical cancer: a global health crisis, Cancer, 123, 13, pp. 2404-2412, (2017)
[6] Poddar P., Maheshwari A., Surgery for cervical cancer: consensus & controversies, Indian J Med Res, 154, 2, pp. 284-292, (2021)
[7] Fontham E.T.H., Wolf A.M.D., Church T.R., Etzioni R., Flowers C.R., Herzig A., Et al., Cervical cancer screening for individuals at average risk: 2020 guideline update from the American cancer society, Cancer J Clin, 70, 5, pp. 321-346, (2020)
[8] Crosbie E.J., Einstein M.H., Franceschi S., Kitchener H.C., Human papillomavirus and cervical cancer, Lancet, 382, 9895, pp. 889-899, (2013)
[9] Wang H., Zhou X., Li C., Yan S., Feng C., He J., Et al., The emerging role of pyroptosis in pediatric cancers: from mechanism to therapy, J Hematol Oncol, 15, 1, pp. 1-21, (2022)
[10] Tong X., Tang R., Xiao M., Xu J., Wang W., Zhang B., Et al., Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and Cuproptosis research, J Hematol Oncol, 15, 1, (2022)

← 1 2 3 4 5 6 7 8 9 10 →